PDL BioPharma, Inc. Convertible Debt
PDL BioPharma, Inc. had Convertible Debt of $137.88 billion as of 2011-09-30, per its 10-Q filed 2011-11-09.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2011-11-09
- 2011-09-30: Convertible Debt $137.88B.
- 2011-06-30: Convertible Debt $136.83B.
| Period end | Convertible Debt |
|---|---|
| 2011-09-30 | $137.88B 10-Q · filed 2011-11-09 |
| 2011-06-30 | $136.83B 10-Q · filed 2011-07-29 |